Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3489)
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
10,491
Price
$52.99
Total Value
$555.92K
Shares Held After
0
% of Holdings
100.0%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
654
Price
$44.16
Total Value
$28.88K
Shares Held After
0
% of Holdings
100.0%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
1,887
Price
$186.19
Total Value
$351.34K
Shares Held After
84,907
% of Holdings
2.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
1,855
Price
$78.10
Total Value
$144.88K
Shares Held After
4,518,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
10,677
Price
$77.46
Total Value
$827.02K
Shares Held After
4,520,302
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
6,067
Price
$76.53
Total Value
$464.29K
Shares Held After
4,530,979
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
1,401
Price
$75.61
Total Value
$105.93K
Shares Held After
4,537,046
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
375
Price
$78.19
Total Value
$29.32K
Shares Held After
715,686
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
10,519
Price
$77.61
Total Value
$816.36K
Shares Held After
716,061
% of Holdings
1.4%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
6,955
Price
$76.72
Total Value
$533.57K
Shares Held After
726,580
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
2,151
Price
$75.75
Total Value
$162.94K
Shares Held After
733,535
% of Holdings
0.3%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
5,200
Price
$1.76
Total Value
$9.17K
Shares Held After
92,348
% of Holdings
5.3%
Acumen Pharmaceuticals, Inc. (ABOS)
OConnell Daniel Joseph — Director
Shares
12,941
Price
$1.76
Total Value
$22.83K
Shares Held After
598,898
% of Holdings
2.1%
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
1,722
Price
$77.41
Total Value
$133.30K
Shares Held After
81,165
% of Holdings
2.1%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
107
Price
$79.52
Total Value
$8.51K
Shares Held After
111,312
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
686
Price
$78.71
Total Value
$54.00K
Shares Held After
111,419
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,521
Price
$77.46
Total Value
$117.82K
Shares Held After
112,105
% of Holdings
1.3%
Enliven Therapeutics, Inc. (ELVN)
Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Shares
50,000
Price
$29.13
Total Value
$1.46M
Shares Held After
765,188
% of Holdings
6.1%
Enliven Therapeutics, Inc. (ELVN)
Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Shares
41,198
Price
$24.90
Total Value
$1.03M
Shares Held After
815,188
% of Holdings
4.8%
Enliven Therapeutics, Inc. (ELVN)
Heyman Richard A. — Director
Shares
4,285
Price
$25.00
Total Value
$107.13K
Shares Held After
25,107
% of Holdings
14.6%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
24,678
Price
$0.61
Total Value
$15.05K
Shares Held After
2,368,849
% of Holdings
1.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
9,075
Price
$6.27
Total Value
$56.90K
Shares Held After
741,292
% of Holdings
1.2%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
6,390
Price
$27.28
Total Value
$174.32K
Shares Held After
20,439
% of Holdings
23.8%
Ainos, Inc. (AIMD)
Taiwan Carbon Nano Technology Corp — 10% Owner
Shares
431
Price
$1.86
Total Value
$801.66
Shares Held After
1,035,925
% of Holdings
0.0%
Fate Therapeutics, Inc. (FATE)
TAHL CINDY — Chief Legal and Compliance Officer
Shares
10,589
Price
$1.06
Total Value
$11.28K
Shares Held After
387,081
% of Holdings
2.7%
Fate Therapeutics, Inc. (FATE)
Valamehr Bahram — Director
Shares
5,190
Price
$1.07
Total Value
$5.56K
Shares Held After
329,708
% of Holdings
1.5%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
20,000
Price
$16.55
Total Value
$331.00K
Shares Held After
366,155
% of Holdings
5.5%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
1,053
Price
$174.17
Total Value
$183.40K
Shares Held After
57,037
% of Holdings
1.8%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,223
Price
$174.17
Total Value
$561.35K
Shares Held After
315,407
% of Holdings
1.0%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
3,251
Price
$174.17
Total Value
$566.23K
Shares Held After
86,794
% of Holdings
3.6%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
1,660
Price
$173.87
Total Value
$288.62K
Shares Held After
90,045
% of Holdings
1.8%
INSMED Inc (INSM)
Bonstein Sara — Chief Financial Officer
Shares
1,447
Price
$174.17
Total Value
$252.02K
Shares Held After
80,506
% of Holdings
1.8%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
2,059
Price
$174.17
Total Value
$358.62K
Shares Held After
107,601
% of Holdings
1.9%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
5,000
Price
$30.00
Total Value
$150.00K
Shares Held After
61,740
% of Holdings
7.5%
Alumis Inc. Common Stock (ALMS)
Foresite Labs, LLC — 10% Owner
Shares
294,117
Price
$17.00
Total Value
$5.00M
Shares Held After
2,908,332
% of Holdings
10.1%
Alumis Inc. Common Stock (ALMS)
Foresite Labs, LLC — 10% Owner
Shares
117,647
Price
$17.00
Total Value
$2.00M
Shares Held After
5,702,536
% of Holdings
2.1%
Alumis Inc. Common Stock (ALMS)
Foresite Capital Management VI LLC — 10% Owner
Shares
294,117
Price
$17.00
Total Value
$5.00M
Shares Held After
2,908,332
% of Holdings
10.1%
Alumis Inc. Common Stock (ALMS)
Foresite Capital Management VI LLC — 10% Owner
Shares
117,647
Price
$17.00
Total Value
$2.00M
Shares Held After
5,702,536
% of Holdings
2.1%
Alumis Inc. Common Stock (ALMS)
Tananbaum James B. — Director
Shares
294,117
Price
$17.00
Total Value
$5.00M
Shares Held After
2,908,332
% of Holdings
10.1%
Alumis Inc. Common Stock (ALMS)
Tananbaum James B. — Director
Shares
117,647
Price
$17.00
Total Value
$2.00M
Shares Held After
5,702,536
% of Holdings
2.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
300
Price
$75.20
Total Value
$22.56K
Shares Held After
4,538,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,135
Price
$74.38
Total Value
$605.06K
Shares Held After
4,538,747
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
11,565
Price
$73.65
Total Value
$851.81K
Shares Held After
4,546,882
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
400
Price
$75.16
Total Value
$30.06K
Shares Held After
735,686
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,085
Price
$74.38
Total Value
$601.34K
Shares Held After
736,086
% of Holdings
1.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
11,515
Price
$73.64
Total Value
$848.02K
Shares Held After
744,171
% of Holdings
1.5%
Acumen Pharmaceuticals, Inc. (ABOS)
Zuga Matt — CFO & Chief Business Officer
Shares
6,888
Price
$1.82
Total Value
$12.51K
Shares Held After
209,951
% of Holdings
3.2%
Acumen Pharmaceuticals, Inc. (ABOS)
Barton Russell — Chief Operating Officer
Shares
3,530
Price
$1.86
Total Value
$6.56K
Shares Held After
123,269
% of Holdings
2.8%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
30,092
Price
$1.82
Total Value
$54.87K
Shares Held After
97,548
% of Holdings
23.6%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
6,819
Price
$1.82
Total Value
$12.38K
Shares Held After
127,640
% of Holdings
5.1%
Showing 2701–2750 of 3489 transactions (page 55 of 70)